ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $0 | -100.0% | 12,300 | -68.9% | 0.00% | -100.0% |
| Q2 2022 | $31,000 | -47.5% | 39,500 | -59.7% | 0.00% | -66.7% |
| Q1 2022 | $59,000 | -40.4% | 98,000 | -43.1% | 0.00% | 0.0% |
| Q4 2021 | $99,000 | +175.0% | 172,200 | +216.5% | 0.00% | +200.0% |
| Q3 2021 | $36,000 | +157.1% | 54,400 | +3.6% | 0.00% | – |
| Q2 2021 | $14,000 | +75.0% | 52,500 | +267.1% | 0.00% | – |
| Q1 2021 | $8,000 | -80.5% | 14,300 | -69.9% | 0.00% | -100.0% |
| Q4 2020 | $41,000 | +412.5% | 47,500 | +229.9% | 0.00% | – |
| Q3 2020 | $8,000 | – | 14,400 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 340,000 | $1,459,000 | 0.53% |
| RTW INVESTMENTS, LP | 4,733,323 | $20,306,000 | 0.31% |
| APIS CAPITAL ADVISORS, LLC | 70,000 | $300,000 | 0.29% |
| Hudson Bay Capital Management LP | 1,800,000 | $7,722,000 | 0.10% |
| COWEN AND COMPANY, LLC | 249,215 | $1,069,000 | 0.05% |
| Kerrisdale Advisers, LLC | 100,000 | $429,000 | 0.05% |
| Woodline Partners LP | 496,172 | $2,129,000 | 0.04% |
| Shay Capital LLC | 60,000 | $257,000 | 0.03% |
| Walleye Capital LLC | 231,037 | $991,000 | 0.03% |
| BOOTHBAY FUND MANAGEMENT, LLC | 212,700 | $912,000 | 0.02% |